<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Our_Sneaky_Reality_Regarding_Temozolomide</id>
		<title>Our Sneaky Reality Regarding Temozolomide - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Our_Sneaky_Reality_Regarding_Temozolomide"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Our_Sneaky_Reality_Regarding_Temozolomide&amp;action=history"/>
		<updated>2026-05-04T04:48:14Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Our_Sneaky_Reality_Regarding_Temozolomide&amp;diff=193904&amp;oldid=prev</id>
		<title>Leek58pond: Our Sneaky Reality Regarding Temozolomide</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Our_Sneaky_Reality_Regarding_Temozolomide&amp;diff=193904&amp;oldid=prev"/>
				<updated>2017-06-24T21:29:07Z</updated>
		
		<summary type="html">&lt;p&gt;Our Sneaky Reality Regarding Temozolomide&lt;/p&gt;
&lt;table class='diff diff-contentalign-left'&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;col class='diff-marker' /&gt;
				&lt;col class='diff-content' /&gt;
				&lt;tr style='vertical-align: top;'&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Попередня версія&lt;/td&gt;
				&lt;td colspan='2' style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Версія за 21:29, 24 червня 2017&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Рядок 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Рядок 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Admission to intensive care unit &lt;/del&gt;(&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;ICU&lt;/del&gt;) &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;in patients with cancer would make some distress in emotion and quality of life. The decision making is difficult to admit ICU in lung cancer patient. The predictive factors of outcome will be needed. We reviewed the clinical outcome and characteristics of patients with lung cancer who admitted ICU retrospectively. Methods?We retrospectively collected clinical data of patients with lung cancer who admitted ICU from January 2010 to November 2011. Causes of admission, use of mechanical ventilation, presence of do-not-resuscitate, mortality were included. Postsurgical care was excluded in analysis. Results?One hundred thirty one patients were admitted in ICU. For postoperative care ninety three &lt;/del&gt;[http://www.selleckchem.com/products/ABT-888.html &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;www.selleckchem.com/products/ABT-888.html&lt;/del&gt;] &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;patients were admitted &lt;/del&gt;in &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;surgical ICU and excluded&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;We analyzed thirty eight patients of lung cancer. NSCLC patients were 34 (89%) &lt;/del&gt;and &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;SCLC patients 4 (11%)&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;25 patients (66%) were inoperable stage (stage IIIB&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;IV). Causes of admission were acute respiratory failure (78%)&lt;/del&gt;, cardiovascular disease &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;(8%)&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;gastrointestinal bleeding (8%) &lt;/del&gt;and &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;neurologic disease (5%)&lt;/del&gt;. The &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;mortality of ICU was 53% (20/38)&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Seventeen patients and family noticed &lt;/del&gt;the &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;code of do&lt;/del&gt;-&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;not-resuscitation after ICU admission. Twenty nine (79%) patients were received mechanical ventilation and 25 &lt;/del&gt;of &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;29 patients were dead during ICU care. Conclusion?In advanced lung cancer patients, ICU care would not be [http://en.wikipedia.org/wiki/DDR1 DDR1] needed in some conditions. The model &lt;/del&gt;of &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;ICU mortality &lt;/del&gt;in &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;lung cancer should be established for &lt;/del&gt;the &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;purpose of well-dying care&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;JYI LIN WONG1&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;SIEW TECK TIE1, KONG LEONG YU2, PEY JIE VOON2 1Department of Medicine, Sarawak General Hospital, 2Onoclogy Unit, Sarawak &lt;/del&gt;[http://www.selleckchem.com/products/Methazolastone.html &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;learn more&lt;/del&gt;] &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;General Hospital Introduction?Incidence of lung malignancy is rising due &lt;/del&gt;to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;prevalence of smoking&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Adenocarcinoma is &lt;/del&gt;the &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;most common histological subtype worldwide &lt;/del&gt;and &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;in Malaysia&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Its treatments have evolved from &lt;/del&gt;the &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;conventional chemotherapy to targeted therapy. EGFR mutation is an established predictive factor for &lt;/del&gt;the use of &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;tyrosine kinase inhibitor (TKI). While EGFR mutation has been more commonly associated with Asians&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;its prevalence among different ethnic group among Asians has not be established. Methods?A retrospective study. All patients seen in respiratory unit between Nov 2011 &lt;/del&gt;to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Feb 2013 whom were suffering from lung malignancy were included&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Their characteristics were obtained from clinic cards. Results?A total &lt;/del&gt;of &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;93 patient was included in the analysis&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Adenocarcinoma was found &lt;/del&gt;in &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;53% &lt;/del&gt;(&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;n?=?49&lt;/del&gt;) &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;of the cases &lt;/del&gt;and &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;squamous cell carcinoma in 25% (n?=?23) of the cases&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Overall&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;lung carcinoma suffers are more likely to be male (69%&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;n?=?64) &lt;/del&gt;and &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;smokers (56% n?=?52)&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;However&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;for subtype adenocarcinoma female (OR 2&lt;/del&gt;.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;48 p?=?0&lt;/del&gt;.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;048&lt;/del&gt;) &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;and non&lt;/del&gt;-&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;smokers &lt;/del&gt;(&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;OR 7.09&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;p?&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Mesenchymal stem cells &lt;/ins&gt;(&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;MSCs&lt;/ins&gt;) &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;are an attractive source for therapy; &lt;/ins&gt;[http://www.selleckchem.com/products/ABT-888.html &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;learn more&lt;/ins&gt;] &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;reduced ethical concern, ease &lt;/ins&gt;in &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;expansion, as off-the-shelf stem cells&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;MSCs exert immune suppressive properties, providing them with the potential for immune suppressive therapy such as autoimmunity, asthma, allergic rhinitis &lt;/ins&gt;and &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;graft versus host disease&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;In addition&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;MSCs, as well as other stem cells, can be applied for bone and cartilage repair&lt;/ins&gt;, cardiovascular disease, and &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;neural repair/protection&lt;/ins&gt;. The &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;data thus far with MSCs are mixed&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;This review discusses &lt;/ins&gt;the &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;immune&lt;/ins&gt;-&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;enhancing properties &lt;/ins&gt;of &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;MSCs to explain the possible confounds &lt;/ins&gt;of &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;inflammatory microenvironment &lt;/ins&gt;in the &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;MSCs therapy&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Although this review focuses on MSCs&lt;/ins&gt;, [http://www.selleckchem.com/products/Methazolastone.html &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;selleck compound&lt;/ins&gt;] &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;the information can be extrapolated &lt;/ins&gt;to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;other stem cells&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;The review summarizes &lt;/ins&gt;the &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;biology of MSCs, including multilineage differentiation potential, transdifferentiation capability, &lt;/ins&gt;and &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;immunological effects&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;We emphasize &lt;/ins&gt;the &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;key concepts that may predict &lt;/ins&gt;the use of &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;these cells in medicine&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;namely, the application of these cells from the bench &lt;/ins&gt;to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;the bedside&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Prospects on immunotherapy, neuroregeneration, and cardiovascular repair are used as examples &lt;/ins&gt;of &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;tissue repair&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Clin Trans Sci 2011; Volume 4: 380�C386 &amp;quot;&amp;quot;4005&amp;quot;	&amp;quot;Hyponatremia is a common electrolyte disorder &lt;/ins&gt;in &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;patients with heart failure &lt;/ins&gt;(&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;HF&lt;/ins&gt;) &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;associated with cognitive dysfunction &lt;/ins&gt;and &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;increased mortality and rehospitalization rates&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Loop diuretics worsen renal function&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;produce neurohormonal activation&lt;/ins&gt;, and &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;induce electrolyte imbalances&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Lixivaptan is a selective&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;oral vasopressin V2-receptor antagonist that improves hyponatremia by promoting electrolyte-free aquaresis without significant side effects&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;The Treatment of Hyponatremia Based on Lixivaptan in NYHA Class [http://en&lt;/ins&gt;.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;wikipedia.org/wiki/DDR1 DDR1] III/IV Cardiac Patient Evaluation (BALANCE&lt;/ins&gt;) &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;study is a randomized, double&lt;/ins&gt;-&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;blind, placebo-controlled, phase 3 trial designed to evaluate the effects of lixivaptan on serum sodium in patients hospitalized with worsening heart failure &lt;/ins&gt;(&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;target N= 650)&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;signs of congestion and serum sodium concentrations&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Leek58pond</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Our_Sneaky_Reality_Regarding_Temozolomide&amp;diff=190472&amp;oldid=prev</id>
		<title>Leek58pond: Створена сторінка: Admission to intensive care unit (ICU) in patients with cancer would make some distress in emotion and quality of life. The decision making is difficult to admi...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Our_Sneaky_Reality_Regarding_Temozolomide&amp;diff=190472&amp;oldid=prev"/>
				<updated>2017-06-17T17:20:52Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Admission to intensive care unit (ICU) in patients with cancer would make some distress in emotion and quality of life. The decision making is difficult to admi...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Admission to intensive care unit (ICU) in patients with cancer would make some distress in emotion and quality of life. The decision making is difficult to admit ICU in lung cancer patient. The predictive factors of outcome will be needed. We reviewed the clinical outcome and characteristics of patients with lung cancer who admitted ICU retrospectively. Methods?We retrospectively collected clinical data of patients with lung cancer who admitted ICU from January 2010 to November 2011. Causes of admission, use of mechanical ventilation, presence of do-not-resuscitate, mortality were included. Postsurgical care was excluded in analysis. Results?One hundred thirty one patients were admitted in ICU. For postoperative care ninety three [http://www.selleckchem.com/products/ABT-888.html www.selleckchem.com/products/ABT-888.html] patients were admitted in surgical ICU and excluded. We analyzed thirty eight patients of lung cancer. NSCLC patients were 34 (89%) and SCLC patients 4 (11%). 25 patients (66%) were inoperable stage (stage IIIB, IV). Causes of admission were acute respiratory failure (78%), cardiovascular disease (8%), gastrointestinal bleeding (8%) and neurologic disease (5%). The mortality of ICU was 53% (20/38). Seventeen patients and family noticed the code of do-not-resuscitation after ICU admission. Twenty nine (79%) patients were received mechanical ventilation and 25 of 29 patients were dead during ICU care. Conclusion?In advanced lung cancer patients, ICU care would not be [http://en.wikipedia.org/wiki/DDR1 DDR1] needed in some conditions. The model of ICU mortality in lung cancer should be established for the purpose of well-dying care. JYI LIN WONG1, SIEW TECK TIE1, KONG LEONG YU2, PEY JIE VOON2 1Department of Medicine, Sarawak General Hospital, 2Onoclogy Unit, Sarawak [http://www.selleckchem.com/products/Methazolastone.html learn more] General Hospital Introduction?Incidence of lung malignancy is rising due to prevalence of smoking. Adenocarcinoma is the most common histological subtype worldwide and in Malaysia. Its treatments have evolved from the conventional chemotherapy to targeted therapy. EGFR mutation is an established predictive factor for the use of tyrosine kinase inhibitor (TKI). While EGFR mutation has been more commonly associated with Asians, its prevalence among different ethnic group among Asians has not be established. Methods?A retrospective study. All patients seen in respiratory unit between Nov 2011 to Feb 2013 whom were suffering from lung malignancy were included. Their characteristics were obtained from clinic cards. Results?A total of 93 patient was included in the analysis. Adenocarcinoma was found in 53% (n?=?49) of the cases and squamous cell carcinoma in 25% (n?=?23) of the cases. Overall, lung carcinoma suffers are more likely to be male (69%, n?=?64) and smokers (56% n?=?52). However, for subtype adenocarcinoma female (OR 2.48 p?=?0.048) and non-smokers (OR 7.09, p?&lt;/div&gt;</summary>
		<author><name>Leek58pond</name></author>	</entry>

	</feed>